Webinar Report Part Two – Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake.
World Pharmaceutical and Biotech Journal
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 67,000 employees worldwide.
Webinar report Part One - Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake.
World Pharmaceutical and Biotech Journal
Part Three: Before we are patients, we are people. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
World Pharmaceutical and Biotech Journal
Part Two: Driving change through NHS infrastructure. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
World Pharmaceutical and Biotech Journal
Part One: Competition and collaboration. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences.
World Pharmaceutical and Biotech Journal
Public Policy Projects (PPP) and IQVIA joined forces to reflect upon the learnings of 2020 in a ‘past, present and future’ virtual fireside pre-Christmas conversation with Lord Ara Darzi, Blake Dark, Dr William van’t Hoff, Matthew Gould and Ben Osborn and Angela McFarlane.
Accountable Care Journal
Speaking at the Public Policy Projects’ (PPP) Annual Conference 2020, a panel of experts discuss how the UK has situated itself as a global leader in genomic research, and the importance that this continues despite the challenges of Covid-19
Accountable Care Journal
Covid-19 is changing the landscape of UK clinical research, but will these reforms last beyond the pandemic?
Accountable Care Journal
IQVIA has joined the ACCORD-2 collaboration to fast-track the development of new treatments for Covid-19.
Accountable Care Journal
IQVIA, one of the UK’s leading providers of clinical research, has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre, to immediately commence a country-wide testing programme of UK households for Covid-19 infection and immunity.
Accountable Care Journal
IQVIA’s European strategy and value conference 2019 offered the ideal forum for health experts and life science professionals to discuss developments across the sector. This is what was said.
Accountable Care Journal
VIDEO: launching the report for the IQVIA and Public Policy Projects White Paper identifying where the life sciences industrial strategy needs to go further in the context of Brexit.
Accountable Care Journal
Become a Partner
If you would like to enquire about working with Public Policy Projects, please contact partnerships@publicpolicyprojects.com for more information.